WO2002062996A1 - Nouveau peptide physiologiquement actif et utilisation de ce peptide - Google Patents
Nouveau peptide physiologiquement actif et utilisation de ce peptide Download PDFInfo
- Publication number
- WO2002062996A1 WO2002062996A1 PCT/JP2002/000837 JP0200837W WO02062996A1 WO 2002062996 A1 WO2002062996 A1 WO 2002062996A1 JP 0200837 W JP0200837 W JP 0200837W WO 02062996 A1 WO02062996 A1 WO 02062996A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptide
- physiologically active
- active peptide
- novel physiologically
- usable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02710463A EP1357187A4 (en) | 2001-02-02 | 2002-02-01 | NOVEL PHYSIOLOGICALLY ACTIVE PEPTIDE AND USE OF THIS PEPTIDE |
US10/470,951 US20040072293A1 (en) | 2001-02-02 | 2002-02-01 | Novel physiologically active peptide and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-26798 | 2001-02-02 | ||
JP2001026798 | 2001-02-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002062996A1 true WO2002062996A1 (fr) | 2002-08-15 |
Family
ID=18891557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/000837 WO2002062996A1 (fr) | 2001-02-02 | 2002-02-01 | Nouveau peptide physiologiquement actif et utilisation de ce peptide |
Country Status (3)
Country | Link |
---|---|
US (1) | US20040072293A1 (ja) |
EP (1) | EP1357187A4 (ja) |
WO (1) | WO2002062996A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998046620A1 (en) * | 1997-04-17 | 1998-10-22 | Millennium Pharmaceuticals, Inc. | A novel human g-protein coupled receptor |
WO1999006550A2 (en) * | 1997-08-01 | 1999-02-11 | Genset | 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
WO2000031334A2 (de) * | 1998-11-24 | 2000-06-02 | Walter Marte | Verfahren und apparatur zur reduktion von küpen- und schwefelfarbstoffen |
WO2000052022A1 (en) * | 1999-03-01 | 2000-09-08 | Millennium Pharmaceuticals, Inc. | Secreted proteins and nucleic acids encoding them |
-
2002
- 2002-02-01 EP EP02710463A patent/EP1357187A4/en not_active Withdrawn
- 2002-02-01 US US10/470,951 patent/US20040072293A1/en not_active Abandoned
- 2002-02-01 WO PCT/JP2002/000837 patent/WO2002062996A1/ja not_active Application Discontinuation
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998046620A1 (en) * | 1997-04-17 | 1998-10-22 | Millennium Pharmaceuticals, Inc. | A novel human g-protein coupled receptor |
WO1999006550A2 (en) * | 1997-08-01 | 1999-02-11 | Genset | 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN PROSTATE |
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
WO2000031334A2 (de) * | 1998-11-24 | 2000-06-02 | Walter Marte | Verfahren und apparatur zur reduktion von küpen- und schwefelfarbstoffen |
WO2000052022A1 (en) * | 1999-03-01 | 2000-09-08 | Millennium Pharmaceuticals, Inc. | Secreted proteins and nucleic acids encoding them |
Non-Patent Citations (3)
Title |
---|
KAZUHIRO SHIBATA ET AL.: "RIKEN integrated sequence analysis (RISA) system-384-format sequencing pipeline with 384 multicapillary sequencer", GENOME RESEARCH, vol. 10, no. 11, November 2000 (2000-11-01), pages 1757 - 1771, XP002951503 * |
PIERO CARNINCI ET AL.: "Normalization and subtraction of cap-trapper-selected cDNAs to prepare full-length cDNA libraries for rapid discovery of new genes", GENOME RESEARCH, vol. 10, no. 10, October 2000 (2000-10-01), pages 1617 - 1630, XP002944079 * |
RACHEL PARKER ET AL.: "Y-receptor-like genes GPR72 and GPR73: molecular cloning, genomic organisation and assignment to human chromosome 11q21.1 and 2p14 and mouse chromosome 9 and 6", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1491, 2000, pages 369 - 375, XP004275650 * |
Also Published As
Publication number | Publication date |
---|---|
EP1357187A1 (en) | 2003-10-29 |
US20040072293A1 (en) | 2004-04-15 |
EP1357187A4 (en) | 2004-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002099084A3 (en) | Composite binding polypeptides | |
WO2003057134A8 (en) | Specific binding agents of human angiopoietin-2 | |
EP1777234A3 (en) | Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 | |
WO2004009622A3 (en) | Protein complexes of cellular networks underlying the development of cancer and other diseases | |
WO2003031462A3 (en) | Nogo receptor-mediated blockade of axonal growth | |
WO2000040614A3 (en) | Characterization of the soc/crac calcium channel protein family | |
MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
WO2001051520A9 (en) | Nogo receptor-mediated blockade of axonal growth | |
WO2003076592A3 (en) | Novel method for delivery and intracellular synthesis of sirna molecules | |
WO2003020932A1 (fr) | Nouvelles proteines de secretion et adn associe | |
AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
WO2007087053A3 (en) | Bmp-7 variant compositions, methods and uses | |
WO2003087138A3 (en) | Methods for identifying polypeptide factors interacting with rna | |
EP2083018A3 (en) | Compositions and methods relating to STOP-1 | |
WO2003022868A3 (en) | Metal binding proteins and associated methods | |
WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases | |
WO2003093419A3 (en) | Preventing secondary lymphedema with vegf-d dna | |
WO2002062996A1 (fr) | Nouveau peptide physiologiquement actif et utilisation de ce peptide | |
AU2003205605A1 (en) | Conformation-specific, protein kinase binding peptides and related methods and products | |
WO2002070563A3 (en) | Nuclear hormone receptor ligand binding domain | |
TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers | |
WO2001002429A3 (en) | Angiopoietin-6 and uses thereof | |
WO2004035783A3 (en) | Protein complexes of the tumor-necrosis-factor-alpha (tnf-alpha) signalling pathway | |
WO2003099863A3 (en) | Resistin binding proteins, their preparation and use | |
AU2001292326A1 (en) | Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002710463 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10470951 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2002710463 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002710463 Country of ref document: EP |